Platinum(IV) Prodrugs with Cancer Stem Cell Inhibitory Effects on Lung Cancer for Overcoming Drug Resistance
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Platinum(IV) Prodrugs with Cancer Stem Cell Inhibitory Effects on Lung Cancer for Overcoming Drug Resistance
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2022-05-30
DOI
10.1021/acs.jmedchem.2c00472
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Acquired resistance to targeted therapies in NSCLC: Updates and evolving insights
- (2020) Catherine B. Meador et al. PHARMACOLOGY & THERAPEUTICS
- Emerging therapeutic agents for advanced non-small cell lung cancer
- (2020) Ruqin Chen et al. Journal of Hematology & Oncology
- A New Multi‐action Pt(IV) Conjugate with Oleate and Cinnamate Ligands Targets Human Epithelial Growth Factor Receptor HER2 in Aggressive Breast Cancer Cells
- (2020) Hana Kostrhunova et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Design, synthesis and biological evaluation of novel potent STAT3 inhibitors based on BBI608 for cancer therapy
- (2020) Kai-Rui Feng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
- (2020) Connor O’Leary et al. Pharmaceuticals
- Long term follow-up of EGFR mutated NSCLC cases
- (2020) Gad Rennert et al. Translational Oncology
- Role of OCT4 in cancer stem-like cells and chemotherapy resistance
- (2019) Ismail S. Mohiuddin et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Platinum (IV) Derivatives with Cinnamate Axial Ligands as Potent Agents Against Both Differentiated and Tumorigenic Cancer Stem Rhabdomyosarcoma Cells
- (2019) Juraj Zajac et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The side effects of platinum-based chemotherapy drugs: a review for chemists
- (2018) Rabbab Oun et al. DALTON TRANSACTIONS
- ALDH as a Stem Cell marker in solid tumors
- (2018) E Mariel Toledo-Guzman et al. Current Stem Cell Research & Therapy
- ROS and the DNA damage response in cancer
- (2018) Upadhyayula Sai Srinivas et al. Redox Biology
- Curcumin Suppresses Lung Cancer Stem Cells via Inhibiting Wnt/β-catenin and Sonic Hedgehog Pathways
- (2017) Jian-Yun Zhu et al. PHYTOTHERAPY RESEARCH
- The challenge of targeting cancer stem cells to halt metastasis
- (2017) Alice Agliano et al. SEMINARS IN CANCER BIOLOGY
- Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation
- (2016) José Alexandre Ferreira et al. DRUG RESISTANCE UPDATES
- MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
- (2016) Mark M. Awad et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications
- (2016) Silvia Juliana Serrano-Gomez et al. Molecular Cancer
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers
- (2015) Ping Wang et al. Clinical Lung Cancer
- Suppression of cancer relapse and metastasis by inhibiting cancer stemness
- (2015) Youzhi Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The emerging molecular machinery and therapeutic targets of metastasis
- (2015) Yutong Sun et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors
- (2014) Christian Rolfo et al. CANCER TREATMENT REVIEWS
- Evolution of the Cancer Stem Cell Model
- (2014) Antonija Kreso et al. Cell Stem Cell
- Drugging the p53 pathway: understanding the route to clinical efficacy
- (2014) Kian Hoe Khoo et al. NATURE REVIEWS DRUG DISCOVERY
- Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical, Pathologic, and Biologic Features Associated with BRAF Mutations in Non-Small Cell Lung Cancer
- (2013) S. Cardarella et al. CLINICAL CANCER RESEARCH
- Cancer stem cells in lung cancer: Evidence and controversies
- (2013) Muhammad Alamgeer et al. RESPIROLOGY
- DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
- (2012) Wynand P. Roos et al. CANCER LETTERS
- ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
- (2012) Kristin Bergethon et al. JOURNAL OF CLINICAL ONCOLOGY
- Under stress: p53 controls EMT and stemness in pancreatic epithelial cells
- (2011) Tobias Keck et al. CELL CYCLE
- Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform
- (2011) Paola Marcato et al. CELL CYCLE
- p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs
- (2011) Chun-Ju Chang et al. NATURE CELL BIOLOGY
- Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
- (2010) Alex Chang LUNG CANCER
- Elimination of Human Lung Cancer Stem Cells through Targeting of the Stem Cell Factor-c-kit Autocrine Signaling Loop
- (2009) V. Levina et al. CANCER RESEARCH
- Epithelial-mesenchymal transition in cancer development and its clinical significance
- (2009) Masaaki Iwatsuki et al. CANCER SCIENCE
- DNA damage-induced reactive oxygen species (ROS) stress response in Saccharomyces cerevisiae
- (2008) Lori A. Rowe et al. FREE RADICAL BIOLOGY AND MEDICINE
- -H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin
- (2008) A. Kinner et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started